ED50 and ED95 of Intrathecal Hyperbaric Bupivacaine With Fentanyl for Transurethral Prostatectomy in Elderly Patients

ED50 and ED95 of Intrathecal Hyperbaric Bupivacaine With Fentanyl for Transurethral Prostatectomy in Elderly Patients : a Prospective Double-blinded Randomized Trial

As people age, the incidence of prostate hyperplasia increases. So patients under Transurethral Resection of Prostate(TURP) or Holmium Laser Ennucleation of Prostate(HoLEP) are mostly ole age people. Most old age patient has several underlying disease. So patients can develop high mortality and morbidity. Most surgeries for Prostate Resection are taken under Spinal anesthesia. Adequate block level for Prostate Resection is T10. But sometimes, old age patients can develop severe complication after spinal anesthesia. So we started this study to know the adequate drug concentration for Spinal anesthesia taken for Prostate Resection surgery.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

As people age, the incidence of prostate hyperplasia increases. So patients under Transurethral Resection of Prostate(TURP) or Holmium Laser Ennucleation of Prostate(HoLEP) are mostly ole age people. Most old age patient has several underlying disease. So patients can develop high mortality and morbidity. Most surgeries for Prostate Resection are taken under Spinal anesthesia. Adequate block level for Prostate Resection is T10. But sometimes, old age patients can develop severe hypotension and vital unstability due to unintentional high sensory and motor blocks. These complications are due to the decreased cerebrospinal fluid volume with increase of age. So we started this study to know the adequate drug concentration for Spinal anesthesia taken for Prostate Resection surgery.

Study Type

Interventional

Enrollment (Actual)

13

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Yeongdeungpo-gu
      • Seoul, Yeongdeungpo-gu, Korea, Republic of, KS013
        • KangNam Sacred Heart Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 100 years (Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Patients scheduled for TURP & HoLEP under spinal anesthesia
  • Male between 65 and 100
  • The American Society of Anesthesiologists physical status class 1 or 2

Exclusion Criteria:

  • Patients with coagulopathy
  • Patients with infectious disease
  • Patients with a drug allergy
  • Patients under 50kg or over 100kg
  • In case of switching to general anesthesia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: bupivacaine 6mg
bupivacaine dose
Other: bupivacaine 7mg
bupivacaine dose
Other: bupivacaine 8mg
bupivacaine dose
Other: bupivacaine 9mg
bupivacaine dose
Other: bupivacaine 10mg
bupivacaine dose
Other: bupivacaine 11mg
bupivacaine dose
Other: bupivacaine 12mg
bupivacaine dose

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ED50 and ED95 of intrathecal hyperbaric bupivacaine with fentanyl for transurethral prostatectomy in elderly patients
Time Frame: 2years
ED50(50% Effective dose) and ED95(95% Effective dose) of intrathecal hyperbaric bupivacaine with fentanyl for transurethral prostatectomy in elderly patients
2years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
comparison of incidence of complications(hypotension, nausea/vomiting and shivering) during perioperative period
Time Frame: 2years
comparison of incidence of complications(hypotension, nausea/vomiting and shivering) during perioperative period
2years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Eun Mi Choi, MD, Hallym University Kangnam Sacred Heart Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2018

Primary Completion (Actual)

May 31, 2020

Study Completion (Actual)

September 1, 2020

Study Registration Dates

First Submitted

August 1, 2018

First Submitted That Met QC Criteria

October 10, 2018

First Posted (Actual)

October 12, 2018

Study Record Updates

Last Update Posted (Actual)

March 21, 2022

Last Update Submitted That Met QC Criteria

March 18, 2022

Last Verified

April 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Old Age

Clinical Trials on Bupivacaine

3
Subscribe